Genisphere Adapts 3DNA® Dendrimer Technology to Lateral Flow Point-of-Care Assays

Published: Jul 17, 2012

HATFIELD, Pa.--(BUSINESS WIRE)--Genisphere has adapted its pioneering 3DNA Dendrimer Signal Amplification technology for Lateral Flow (LF) Point-of-Care (POC) assays, providing improved sensitivity and enabling a broad new array of POC tests. LF assays represent a unique and growing class of POC tests designed to rapidly diagnose patients within clinically actionable timeframes.

Back to news